Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoatrophic Diabetes Mellitus”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT00672919
What this trial is testing

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Who this might be right for
Diabetes Mellitus
Takeda 305
Large-scale testing (Phase 3)Study completedNCT00772174
What this trial is testing

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 418
Large-scale testing (Phase 3)Ended earlyNCT00762684
What this trial is testing

Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 8
Large-scale testing (Phase 3)Study completedNCT00225277
What this trial is testing

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 547
Post-approval studies (Phase 4)Study completedNCT00754403
What this trial is testing

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 312
Large-scale testing (Phase 3)Study completedNCT00727857
What this trial is testing

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 600
Large-scale testing (Phase 3)Ended earlyNCT00762112
What this trial is testing

Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 316
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Large-scale testing (Phase 3)Study completedNCT00395512
What this trial is testing

Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 655
Testing effectiveness (Phase 2)Ended earlyNCT00722917
What this trial is testing

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 323
Large-scale testing (Phase 3)Ended earlyNCT00759720
What this trial is testing

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 447
Large-scale testing (Phase 3)Study completedNCT00286442
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 527
Large-scale testing (Phase 3)Study completedNCT00521742
What this trial is testing

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Who this might be right for
Diabetes Mellitus
Takeda 300
Large-scale testing (Phase 3)Study completedNCT00286468
What this trial is testing

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 500
Testing effectiveness (Phase 2)Ended earlyNCT00763347
What this trial is testing

Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 82
Not applicableStudy completedNCT00449553
What this trial is testing

Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

Who this might be right for
Diabetes Mellitus
Takeda 326
Testing effectiveness (Phase 2)Study completedNCT00762736
What this trial is testing

Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 704
Large-scale testing (Phase 3)Study completedNCT00770952
What this trial is testing

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 91
Testing effectiveness (Phase 2)Study completedNCT00653185
What this trial is testing

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 369
Large-scale testing (Phase 3)Active Not RecruitingNCT02262832
What this trial is testing

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

Who this might be right for
LipodystrophyDiabetesHyperlipidemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Next Page